靶向主要外膜蛋白的新型亲和毒素在体外和体内抗沙眼衣原体感染的疗效
研究将针对沙眼衣原体主要外膜蛋白(MOMP)的亲和体ZMOMP:461与修饰的假单胞菌外毒素(PE38KDEL)及细胞穿透肽(CPP)融合,构建亲和毒素Z461X-CPP。体外实验显示Z461X-CPP被沙眼衣原体感染细胞摄取后诱导细胞凋亡;动物模型中Z461X显著缩短沙眼衣原体感染持续时间并防止小鼠生殖系统病理损伤。
要点
- Z461X-CPP由MOMP特异性亲和体ZMOMP:461与PE38KDEL及CPP融合而成。
- 体外实验中Z461X-CPP被沙眼衣原体感染细胞摄取后诱导细胞凋亡。
- 动物模型中Z461X显著缩短沙眼衣原体感染持续时间并防止生殖系统病理损伤。
核心结论
- MOMP特异性亲和毒素在靶向治疗沙眼衣原体感染方面具有很大潜力。
研究设计与样本
- 研究将MOMP特异性亲和体ZMOMP:461与修饰的假单胞菌外毒素PE38KDEL及细胞穿透肽融合构建亲和毒素Z461X-CPP,并在体外细胞模型和动物模型中评价其作用。
主要发现
- 加入毒素和细胞穿透肽未影响ZMOMP:461与MOMP的亲和能力。
- Z461X-CPP被沙眼衣原体感染细胞摄取后在体外诱导细胞凋亡。
- 动物模型中Z461X显著缩短沙眼衣原体感染持续时间并防止小鼠生殖系统病理损伤。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Targeted therapy is an attractive approach for treating infectious diseases. Affibody molecules have similar capability to antibodies that facilitate molecular recognition in both diagnostic and therapeutic applications. Targeting major outer membrane protein (MOMP) for treating infection of Chlamydia trachomatis, one of the most common sexually transmitted pathogens, is a promising therapeutic approach. Previously, we have reported a MOMP-specific affibody (ZMOMP:461) from phage display library. Here, we first fused it with modified Pseudomonas exotoxin (PE38KDEL) and a cell-penetrating peptide (CPP) to develop an affitoxin, Z461X-CPP. We then verified the addition of both toxin and CPPs that did not affect the affinitive capability of ZMOMP:461 to MOMP. Upon uptake by C trachomatis-infected cells, Z461X-CPP induced cell apoptosis in vitro. In an animal model, Z461X significantly shortened the duration of C trachomatis infection and prevented pathological damage in the mouse reproductive system. These findings provide compelling evidence that the MOMP-specific affitoxin has great potential for targeting therapy of C trachomatis infection.
引用
- Li M, Yang J, Zhou L, et al. Efficacy of a Novel Affitoxin Targeting Major Outer Membrane Protein Against Chlamydia trachomatis In Vitro and In Vivo. J Infect Dis. 2024. PMID: 38723186. doi:10.1093/infdis/jiae257
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。